Literature DB >> 25462626

Organocatalyzed solvent free an efficient novel synthesis of 2,4,5-trisubstituted imidazoles for α-glucosidase inhibition to treat diabetes.

Muhammad Yar1, Marek Bajda2, Sohail Shahzad3, Nisar Ullah4, Mazhar Amjad Gilani5, Muhammad Ashraf6, Abdul Rauf7, Ayesha Shaukat6.   

Abstract

A new and efficient solvent free synthesis of 2,4,5-trisubstituted imidazoles (3a-3j) was achieved by N-acetyl glycine (NAG) catalyzed three components condensation of aldehydes, benzil and ammonium acetate. Our synthetic methodology accommodated a range of various substituted alkyl and aryl aldehydes. Evaluation of α-glucosidase inhibitory activity of these imidazole derivatives revealed that most of them presented good α-glucosidase inhibition at low micro-molar concentrations. Among the synthesized compounds, compound 3c, bearing the ortho-hydroxy phenyl substituent at position 2 displayed the highest inhibitory activity with an IC50 value 74.32±0.59 μM. In silico molecular docking for all compounds and computational studies of the most active compound 3c were also performed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Baker’s yeast; Diabetes; Imidazoles; Molecular modeling; Organocatalysis; α-glucosidase inhibition

Mesh:

Substances:

Year:  2014        PMID: 25462626     DOI: 10.1016/j.bioorg.2014.11.006

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  5 in total

1.  Design and synthesis of new imidazo[1,2-b]pyrazole derivatives, in vitro α-glucosidase inhibition, kinetic and docking studies.

Authors:  Fariba Peytam; Mehdi Adib; Reihaneh Shourgeshty; Maryam Mohammadi-Khanaposhtani; Mehdi Jahani; Somaye Imanparast; Mohammad Ali Faramarzi; Mohammad Mahdavi; Ali Akbar Moghadamnia; Hossein Rastegar; Bagher Larijani
Journal:  Mol Divers       Date:  2019-03-02       Impact factor: 2.943

2.  Synthesis, in vitro [Formula: see text]-glucosidase inhibitory activity, and in silico study of (E)-thiosemicarbazones and (E)-2-(2-(arylmethylene)hydrazinyl)-4-arylthiazole derivatives.

Authors:  Muhammad Ali; Khalid Mohammed Khan; Uzma Salar; Mohammed Ashraf; Muhammad Taha; Abdul Wadood; Sujhla Hamid; Muhammad Riaz; Basharat Ali; Shahbaz Shamim; Farman Ali; Shahnaz Perveen
Journal:  Mol Divers       Date:  2018-05-29       Impact factor: 2.943

3.  Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies.

Authors:  Mohammad Sadegh Asgari; Maryam Mohammadi-Khanaposhtani; Zeinab Sharafi; Mohammad Ali Faramarzi; Hossein Rastegar; Ensieh Nasli Esfahani; Fatemeh Bandarian; Parviz Ranjbar Rashidi; Rahmatollah Rahimi; Mahmood Biglar; Mohammad Mahdavi; Bagher Larijani
Journal:  Mol Divers       Date:  2020-03-18       Impact factor: 2.943

Review 4.  Heterocyclic compounds as a magic bullet for diabetes mellitus: a review.

Authors:  Umme Farwa; Muhammad Asam Raza
Journal:  RSC Adv       Date:  2022-08-16       Impact factor: 4.036

5.  Arylsulfonyl histamine derivatives as powerful and selective α-glucosidase inhibitors.

Authors:  M I Osella; M O Salazar; M D Gamarra; D M Moreno; F Lambertucci; D E Frances; R L E Furlan
Journal:  RSC Med Chem       Date:  2020-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.